Is monitoring of antiplatelet therapy by light transmission aggregometry dependent on instrument and reagent used?
Tinne MonteyneLaura HeiremanDimitri HemelsoetRon H N van SchaikKatrien M J DevreesePublished in: International journal of laboratory hematology (2021)
Light transmission aggregometry in clopidogrel-treated patients is mainly depending on the type of ADP reagent. Comparison of LTA with genotype reveals that the choice of instrument seems less influencing. In contrast, in the healthy individuals, differences could be attributed to the instrument.
Keyphrases
- antiplatelet therapy
- acute coronary syndrome
- patient reported outcomes
- percutaneous coronary intervention
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- magnetic resonance
- coronary artery disease
- peritoneal dialysis
- prognostic factors
- magnetic resonance imaging
- patient reported
- clinical evaluation